tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BTAI is currently covered by 7 analysts with an average price target of $59.67. This is a potential upside of $56.26 (1649.85%) from yesterday's end of day stock price of $3.41.
BioXcel Therapeutics's activity chart (see below) currently has 83 price targets and 89 ratings on display. The stock rating distribution of BTAI is 70.37% BUY, 25.93% HOLD and 3.7% SELL.
Analysts average stock forecasts to be materialized ratio is 63.84% with an average time for these price targets to be met of 289.8 days.
Highest price target for BTAI is $16, Lowest price target is $4, average price target is $21.6.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 23-Jun-2025. First documented stock forecast 02-Apr-2018.
Currently out of the existing stock ratings of BTAI, 19 are a BUY (70.37%), 7 are a HOLD (25.93%), 1 are a SELL (3.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$6.69 (510.69%)
1 months 16 days ago
(23-Jun-2025)
6/19 (31.58%)
$6.35 (384.85%)
564
Sell
$4
$2.69 (205.34%)
$23
7 months 1 days ago
(07-Jan-2025)
4/4 (100%)
$-3.54 (-46.95%)
378
Buy
7 months 2 days ago
(06-Jan-2025)
9/11 (81.82%)
$-52.4 (-74.43%)
446
Hold
$16
$14.69 (1121.37%)
$64
11 months 27 days ago
(12-Aug-2024)
7/10 (70%)
$5.48 (52.09%)
48
Hold
$16
$14.69 (1121.37%)
$56
11 months 30 days ago
(09-Aug-2024)
1/4 (25%)
$4.3 (36.75%)
280
What is BTAI (BioXcel Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?
Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?
Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?
